CBD’s Cardiovascular Effects Changed With the Rat Preparation
CBD produced different cardiovascular findings in conscious, anesthetized and experimentally pithed rats. Results from those preparations should not be combined into a single claim that CBD reliably lowers blood pressure in people.
The study separated central and peripheral mechanisms
Researchers compared hypertensive and normotensive rat strains across several preparations. Conscious animals retained normal behavioral and neural regulation. Anesthetized and pithed preparations allowed specific reflex or peripheral effects to be examined under very different physiological conditions.
Positive and null findings coexisted
Rapid intravenous CBD in anesthetized rats caused brief reductions in heart rate and blood pressure consistent with a reflex response. The heart-rate response diminished markedly after repeat administration. In conscious rats, the tested CBD regimen did not significantly alter the measured cardiovascular parameters.
An isolated tissue result was another level of evidence
CBD also reduced contractile force in isolated atrial tissue. That ex vivo observation is distinct from a beneficial change in a living patient’s heart function. Similarly, pharmacological blockade supported selected receptor mechanisms without demonstrating a clinical hypertension treatment.
Why preparation and administration matter
Anesthetic state, intact reflexes, injection speed, strain and route can all change the response being tested. A transient reflex cannot establish sustained blood-pressure control from oral CBD. The study identifies multiple physiological actions for further investigation, while leaving human efficacy, appropriate dosing and long-term cardiovascular outcomes unresolved.
Related analysis: evaluating cannabis tolerance claims.
Primary research
Kossakowski R; Schlicker E; Toczek M; Weresa J; Malinowska B. Cannabidiol Affects the Bezold-Jarisch Reflex via TRPV1 and 5-HT3 Receptors and Has Peripheral Sympathomimetic Effects in Spontaneously Hypertensive and Normotensive Rats. Frontiers in pharmacology (2019). DOI: 10.3389/fphar.2019.00500.



